Clinical Trial Update: BRCA Mutation Carriers' Platform a Multicenter Study

View source ↗

Summary

A multicenter clinical trial platform for BRCA1 and BRCA2 mutation carriers is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: BRCA1 Mutation, BRCA2 Mutation | Status: RECRUITING